{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:23:36Z","timestamp":1759335816726},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10157-021-02054-3","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T14:03:27Z","timestamp":1616249007000},"page":"779-787","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utility of glomerular Gd-IgA1 staining for indistinguishable cases of IgA nephropathy or Alport syndrome"],"prefix":"10.1007","volume":"25","author":[{"given":"Shinya","family":"Ishiko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadayuki","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Aoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"China","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ninchoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Shima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norishige","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,20]]},"reference":[{"issue":"9","key":"2054_CR1","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1681\/ASN.V991736","volume":"9","author":"CE Kashtan","year":"1998","unstructured":"Kashtan CE. Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol. 1998;9(9):1736\u201350.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2054_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10157-018-1629-4","volume":"23","author":"K Nozu","year":"2019","unstructured":"Nozu K, Nakanishi K, Abe Y, Udagawa T, Okada S, Okamoto T, et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol. 2019;23(2):158\u201368. https:\/\/doi.org\/10.1007\/s10157-018-1629-4.","journal-title":"Clin Exp Nephrol"},{"key":"2054_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1750-1172-7-100","volume":"7","author":"XD Yao","year":"2012","unstructured":"Yao XD, Chen X, Huang GY, Yu YT, Xu ST, Hu YL, et al. Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis. Orphanet J Rare Dis. 2012;7:100. https:\/\/doi.org\/10.1186\/1750-1172-7-100.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2054_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/01913128109064244","volume":"2","author":"JJ Navas-Palacios","year":"1981","unstructured":"Navas-Palacios JJ, Gutierrez-Millet V, Usera-Sarrage G, Garzon-Martin A. IgA nephropathy: an ultrastructural study. Ultrastruct Pathol. 1981;2(2):151\u201361. https:\/\/doi.org\/10.3109\/01913128109064244.","journal-title":"Ultrastruct Pathol"},{"issue":"3","key":"2054_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3109\/00313028409068545","volume":"16","author":"WL Ng","year":"1984","unstructured":"Ng WL, Chan KW, Yeung CK, Kwan S. Peripheral glomerular capillary wall lesions in IgA nephropathy and their implications. Pathology. 1984;16(3):324\u201330. https:\/\/doi.org\/10.3109\/00313028409068545.","journal-title":"Pathology"},{"issue":"1","key":"2054_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/01913128809048473","volume":"12","author":"T Taguchi","year":"1988","unstructured":"Taguchi T, von Bassewitz DB, Grundmann E, Takebayashi S. Ultrastructural changes of glomerular basement membrane in IgA nephritis: relationship to hematuria. Ultrastruct Pathol. 1988;12(1):17\u201326. https:\/\/doi.org\/10.3109\/01913128809048473.","journal-title":"Ultrastruct Pathol"},{"issue":"1","key":"2054_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/path.1711540103","volume":"154","author":"M Morita","year":"1988","unstructured":"Morita M, Sakaguchi H. A quantitative study of glomerular basement membrane changes in IgA nephropathy. J Pathol. 1988;154(1):7\u201318. https:\/\/doi.org\/10.1002\/path.1711540103.","journal-title":"J Pathol"},{"issue":"2","key":"2054_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/path.1711500206","volume":"150","author":"N Yoshikawa","year":"1986","unstructured":"Yoshikawa N, Yoshiara S, Yoshiya K, Matsuo T, Okada S. Lysis of the glomerular basement membrane in children with IgA nephropathy and Henoch-Sh\u00f6nlein nephritis. J Pathol. 1986;150(2):119\u201326. https:\/\/doi.org\/10.1002\/path.1711500206.","journal-title":"J Pathol"},{"issue":"10","key":"2054_CR9","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1681\/ASN.2011050464","volume":"22","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, et al. The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011;22(10):1795\u2013803. https:\/\/doi.org\/10.1681\/ASN.2011050464.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2054_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1089\/mab.2018.0041","volume":"37","author":"K Yamasaki","year":"2018","unstructured":"Yamasaki K, Suzuki H, Yasutake J, Yamazaki Y, Suzuki Y. Galactose-deficient IgA1-specific antibody recognizes GalNAc-modified unique epitope on hinge region of IgA1. Monoclon Antib Immunodiagn Immunother. 2018;37(6):252\u20136. https:\/\/doi.org\/10.1089\/mab.2018.0041.","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"issue":"8","key":"2054_CR11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1093\/ndt\/gfv221","volume":"30","author":"J Yasutake","year":"2015","unstructured":"Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, et al. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy. Nephrol Dial Transplant. 2015;30(8):1315\u201321. https:\/\/doi.org\/10.1093\/ndt\/gfv221.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2054_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.kint.2017.10.019","volume":"93","author":"H Suzuki","year":"2018","unstructured":"Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, et al. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018;93(3):700\u20135. https:\/\/doi.org\/10.1016\/j.kint.2017.10.019.","journal-title":"Kidney Int"},{"issue":"2","key":"2054_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ekir.2019.10.012","volume":"5","author":"M Wang","year":"2020","unstructured":"Wang M, Lv J, Zhang X, Chen P, Zhao M, Zhang H. Secondary IgA nephropathy shares the same immune features with primary IgA nephropathy. Kidney Int Rep. 2020;5(2):165\u201372. https:\/\/doi.org\/10.1016\/j.ekir.2019.10.012.","journal-title":"Kidney Int Rep"},{"key":"2054_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz152","author":"CA Cassol","year":"2019","unstructured":"Cassol CA, Bott C, Nadasdy GM, Alberton V, Malvar A, Nagaraja HN, et al. Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy. Nephrol Dial Transplant. 2019. https:\/\/doi.org\/10.1093\/ndt\/gfz152.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2054_CR15","doi-asserted-by":"publisher","first-page":"14026","DOI":"10.1038\/s41598-020-71101-y","volume":"10","author":"S Ishiko","year":"2020","unstructured":"Ishiko S, Horinouchi T, Fujimaru R, Shima Y, Kaito H, Tanaka R, et al. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases. Sci Rep. 2020;10(1):14026. https:\/\/doi.org\/10.1038\/s41598-020-71101-y.","journal-title":"Sci Rep"},{"key":"2054_CR16","doi-asserted-by":"publisher","first-page":"108483","DOI":"10.1016\/j.clim.2020.108483","volume":"217","author":"L Zhao","year":"2020","unstructured":"Zhao L, Peng L, Yang D, Chen S, Lan Z, Zhu X, et al. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy. Clin Immunol. 2020;217:108483. https:\/\/doi.org\/10.1016\/j.clim.2020.108483.","journal-title":"Clin Immunol"},{"issue":"8","key":"2054_CR17","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2215\/CJN.01000116","volume":"11","author":"N Kamiyoshi","year":"2016","unstructured":"Kamiyoshi N, Nozu K, Fu XJ, Morisada N, Nozu Y, Ye MJ, et al. Genetic, clinical, and pathologic backgrounds of patients with autosomal dominant alport syndrome. Clin J Am Soc Nephrol. 2016;11(8):1441\u20139. https:\/\/doi.org\/10.2215\/CJN.01000116.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"2054_CR18","doi-asserted-by":"publisher","first-page":"e883","DOI":"10.1002\/mgg3.883","volume":"7","author":"T Yamamura","year":"2019","unstructured":"Yamamura T, Nozu K, Minamikawa S, Horinouchi T, Sakakibara N, Nagano C, et al. Comparison between conventional and comprehensive sequencing approaches for genetic diagnosis of Alport syndrome. Mol Genet Genomic Med. 2019;7(9):e883. https:\/\/doi.org\/10.1002\/mgg3.883.","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"2054_CR19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/ki.2013.479","volume":"85","author":"Y Hashimura","year":"2014","unstructured":"Hashimura Y, Nozu K, Kaito H, Nakanishi K, Fu XJ, Ohtsubo H, et al. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV alpha5 chain. Kidney Int. 2014;85(5):1208\u201313. https:\/\/doi.org\/10.1038\/ki.2013.479.","journal-title":"Kidney Int"},{"issue":"9","key":"2054_CR20","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00467-014-2797-4","volume":"29","author":"M Oka","year":"2014","unstructured":"Oka M, Nozu K, Kaito H, Fu XJ, Nakanishi K, Hashimura Y, et al. Natural history of genetically proven autosomal recessive Alport syndrome. Pediatr Nephrol. 2014;29(9):1535\u201344. https:\/\/doi.org\/10.1007\/s00467-014-2797-4.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2054_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000057603","volume":"91","author":"H Kamimura","year":"2002","unstructured":"Kamimura H, Honda K, Nitta K, Horita S, Kobayashi H, Uchida K, et al. Glomerular expression of alpha2(IV) and alpha5(IV) chains of type IV collagen in patients with IgA nephropathy. Nephron. 2002;91(1):43\u201350. https:\/\/doi.org\/10.1159\/000057603.","journal-title":"Nephron"},{"issue":"3","key":"2054_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10157-014-1008-8","volume":"19","author":"Y Masuda","year":"2015","unstructured":"Masuda Y, Yamanaka N, Ishikawa A, Kataoka M, Arai T, Wakamatsu K, et al. Glomerular basement membrane injuries in IgA nephropathy evaluated by double immunostaining for alpha5(IV) and alpha2(IV) chains of type IV collagen and low-vacuum scanning electron microscopy. Clin Exp Nephrol. 2015;19(3):427\u201335. https:\/\/doi.org\/10.1007\/s10157-014-1008-8.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"2054_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000503564","volume":"144","author":"CP Stapleton","year":"2020","unstructured":"Stapleton CP, Kennedy C, Fennelly NK, Murray SL, Connaughton DM, Dorman AM, et al. An exome sequencing study of 10 families with IgA nephropathy. Nephron. 2020;144(2):72\u201383. https:\/\/doi.org\/10.1159\/000503564.","journal-title":"Nephron"},{"issue":"7","key":"2054_CR24","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00467-018-3985-4","volume":"34","author":"J Savige","year":"2019","unstructured":"Savige J, Ariani F, Mari F, Bruttini M, Renieri A, Gross O, et al. Expert consensus guidelines for the genetic diagnosis of Alport syndrome. Pediatr Nephrol. 2019;34(7):1175\u201389. https:\/\/doi.org\/10.1007\/s00467-018-3985-4.","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"2054_CR25","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1046\/j.1523-1755.63.6s.2.x","volume":"63","author":"K Suzuki","year":"2003","unstructured":"Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int. 2003;63(6):2286\u201394. https:\/\/doi.org\/10.1046\/j.1523-1755.63.6s.2.x.","journal-title":"Kidney Int"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02054-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-021-02054-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02054-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T16:06:11Z","timestamp":1622045171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-021-02054-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,20]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2054"],"URL":"https:\/\/doi.org\/10.1007\/s10157-021-02054-3","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,20]]},"assertion":[{"value":"10 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kazumoto Iijima reports grants from Daiichi Sankyo, Co., Ltd., personal fees from Kyowa Kirin Co., Ltd., and Integrated Development Associates, and has a patent on antisense nucleotides for exon skipping therapy in Alport syndrome issued. Kandai Nozu has received consulting fees from Kyowa Kirin Co., Ltd.; lecture fees from Kyowa Kirin Co., Ltd., Novartis Pharmaceuticals Corporation, and Chugai Pharmaceutical Co., Ltd.; and has filed a patent application on the development of antisense nucleotides for exon skipping therapy in Alport syndrome.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were carried out in accordance with the ethical standards of the Institutional Review Board of Kobe University Graduate School of Medicine (IRB approval number B190137) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Comprehensive informed consent was obtained from all individual participants in the study and\/or their guardians regarding the use of the patients\u2019 clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}